SENSEX NIFTY

Food And Drug Administration

Apr 18, 2015 at 10:51 | Source: PTI
Maharashtra's Food and Drugs Administration (FDA) has raided the premises of e-commerce major Snapdeal.com for allegedly selling medicines, including prescription drugs.
Apr 15, 2015 at 13:05 | Source: Moneycontrol.com
Shares of Aurobindo Pharma spiked 2.7 percent to hit a record high of Rs 1,386.90 on Wednesday on US FDA nod for antibiotic drug.
Apr 15, 2015 at 12:57 | Source: PTI
The approval of the oral solution is for strength of 420 grams of Glycol 3350, 11.2 grams of sodium chloride, 5.72 grams of sodium bicarbonate and 1.48 grams of potassium per 4 The product will be manufactured at the company's oral dosage facility in Bengaluru and marketed by Strides in the US, it added.
Apr 15, 2015 at 12:33 | Source: Moneycontrol.com
Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Cefixime for OralSuspension USP, 100mg/5mL and 200mg/5mL (ANDA 204835). The product is ready for launch.
Apr 15, 2015 at 11:51 | Source: Moneycontrol.com
Shares of largecap and midcap pharmas gained strength on Wednesday, up 1-5 percent intraday on getting approval from US Food and Drug Administration (USFDA) for cholesterol and alzheimer drugs.
Apr 09, 2015 at 15:08 | Source: PTI
At present, the company has 11 ANDAs approved out of its Unit IV formulation facility in Hyderabad, manufacturing general injectable products, Aurbindo Pharma added. Aurobindo Pharma shares were trading 1.07 percent up at Rs 1,337.25 per scrip during afternoon trade on the BSE.
Apr 09, 2015 at 12:21 | Source: Moneycontrol.com
Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Atracurium BesylateInjection, 10mg/mL, 5mL single-dose vials (ANDA 206010) and 10mg/mL, 10mL multi-dose vials (ANDA 206011).
Apr 08, 2015 at 15:26 | Source: Moneycontrol.com
Shares of Dr Reddy's Laboratories touched a record high of Rs 3,768 on Wednesday, up 2.4 percent intraday after the drug major and its subsidiary Promius Pharma filed three new drug applications with the US Food and Drug Administration (USFDA).
Apr 08, 2015 at 08:19 | Source: PTI
The Hyderabad-based firm and its subsidiary, Promius Pharma LLC have filed three new drug applications with the US Food and Drug Administration (USFDA), Dr Reddy's Laboratories Ltd said in a statement.
Apr 07, 2015 at 13:03 | Source: Moneycontrol.com
Shares of Glenmark Pharmaceuticals gained 1.5 percent intraday on Tuesday on getting the final approval from the United States Food and Drug Administration (USFDA) for sale of menopause osteoporosis drugs.
Messages on Food And Drug Administration »

BSE/NSE Announcer

Platinum Member

7283 Followers

Glenmark  

Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. Glenmark will commence distribution of the product immediately.

12.04 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

7283 Followers

Glenmark  

the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. Glenmark will commence distribution of the product immediately.

12.04 PM Jul 8th 2014

ahaslaltirm
a

Platinum Member

441 Followers

Wockhardt  

Jun 05, 2014, 04.15 PM IST | Source: PTI Wockhardt recalls 8712 hypertension drug bottles in US mkt According to US Food and Drug Administration (USFDA), Wockhardt USA Inc, a subsidiary of Mumbai-based firm is voluntarily recalling 8,712 bottles of the drug in the American market.

10.30 AM Jul 7th 2014

Neha-Diwan

Platinum Member

808 Followers

Ranbaxy Labs  

Ranbaxy Laboratories Ltd has received approval from the US Food and Drug Administration (FDA) to launch a cheaper copy of Novartis AG`s blood pressure pill Diovan. Ranbaxy will be the first rival drug maker to launch a copy of Diovan in the United States and will be entitled to six months

10.20 AM Jun 30th 2014

Amrita Gaba

New Member

419 Followers

Strides Arcolab  

Strides Arcolab has received regulatory approval to market a skin disease drug in the US. The US Food and Drug Administration (FDA) has allowed the company to sell Methoxsalen capsules of 10 mg strength, Bangalore-based Strides Arcolab said in a statement. The US market for generic Methoxsalen

12.33 PM Jun 9th 2014

Willwin

Platinum Member

367 Followers

Wockhardt  

he U.S. Food and Drug Administration has expressed concerns over production processes at the U.S. unit of Wockhardt and there is a real possibility that its USA unit is banned by USFDA. If that happens the share will sink below 400. For the time being IMO,it will go down to 450-500 range.

10.16 AM May 29th 2014

Willwin

Platinum Member

367 Followers

Wockhardt  

Reuters) - The U.S. Food and Drug Administration has expressed concerns over production processes at the U.S. unit of Wockhardt Ltd (WCKH.NS), a top executive said, possibly adding to a spate of regulatory troubles facing the Indian generic drugmaker. The United States is Wockhardt`s biggest

1.01 PM May 28th 2014

Web Messenger

Platinum Member

281442 Followers

Wockhardt  

Source:NDTV Profit - Mumbai: The US Food and Drug Administration (FDA) has made some observations about the production process of the US unit of Indian generic drugmaker Wockhardt Ltd, the company said on Tuesday. The FDA last year banned Wockhardt's two Indian ...

7.12 PM May 27th 2014

teeyen

Silver Member

6 Followers

Natco Pharma  

before the patent on the medication expires. Teva’s lawsuit, accusing the Food and Drug Administration of improperly dismissing its calls for more testing of generic forms of Copaxone before they go on the U.S. market, was thrown out yesterday by a federal judge in Washington. Copaxone, the company

4.09 PM May 18th 2014

shakira9

New Member

3 Followers

Sun Pharma  

to increased scrutiny from regulators concerned that the quality of drugs made in that country aren’t up to US standards. The concerns prompted Margaret Hamburg, the commissioner of the US Food and Drug Administration (FDA), to go to India in February to meet with pharmaceutical makers there about production

12.14 PM May 15th 2014

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.